MedPath

Influence of large amount substitution fluid on electrolyte change

Not Applicable
Conditions
dialysis
Registration Number
JPRN-UMIN000028172
Lead Sponsor
Kawashima Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
18
Inclusion Criteria

Not provided

Exclusion Criteria

Patient with cancer Patient with CRP where there is remarkable inflammation more than 2 The patient who uses blood catharsis except hemodialysis therapy or the hemodialysis filtration therapy together During the pregnancy or the patient whom I am nursing The patient who has a high disability in the liver, a heart, the lungs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood ionized calcium At the start of therapy, 2 hours after the start of treatment, and at the end of treatment, blood test and concentration measurement in dialysis effluent were conducted.
Secondary Outcome Measures
NameTimeMethod
1. Blood ionized magnesium 2. Blood bicarbonate ion
© Copyright 2025. All Rights Reserved by MedPath